{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:21:33Z","timestamp":1773296493721,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.pupt.2007.04.003","type":"journal-article","created":{"date-parts":[[2007,5,19]],"date-time":"2007-05-19T20:24:31Z","timestamp":1179606271000},"page":"146-151","source":"Crossref","is-referenced-by-count":33,"title":["Tiotropium improves FEV1 in patients with COPD irrespective of smoking status"],"prefix":"10.1016","volume":"21","author":[{"given":"J.","family":"Moita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"B\u00e1rbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2007.04.003_bib1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Executive summary. Bethesda, MD: National Institutes of Health. Updated 2005."},{"key":"10.1016\/j.pupt.2007.04.003_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4081\/monaldi.2005.623","article-title":"COPD and tobacco smoke","volume":"63","author":"Bartal","year":"2005","journal-title":"Monaldi Arch Chest Dis"},{"key":"10.1016\/j.pupt.2007.04.003_bib3","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1136\/bmj.1.6077.1645","article-title":"The natural history of chronic airflow obstruction","volume":"1","author":"Fletcher","year":"1977","journal-title":"BMJ"},{"key":"10.1016\/j.pupt.2007.04.003_bib4","first-page":"253","article-title":"Risk factors for COPD","volume":"39","author":"Buist","year":"1996","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pupt.2007.04.003_bib5","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1164\/ajrccm.149.5.8173761","article-title":"The UCLA population studies of chronic obstructive respiratory disease: XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second","volume":"149","author":"Tashkin","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2007.04.003_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000195837","article-title":"The \u2018healthy smoker\u2019: a phenomenon of health selection?","volume":"57","author":"Becklake","year":"1990","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2007.04.003_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1034\/j.1399-3003.1999.13b21.x","article-title":"Predisposing factors to bacterial colonization in chronic obstruction pulmonary disease exacerbation","volume":"13","author":"Zalacain","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2007.04.003_bib8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1183\/09031936.05.00108904","article-title":"Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers","volume":"26","author":"Willemse","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2007.04.003_bib9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199903043400903","article-title":"A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation","volume":"340","author":"Jorenby","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pupt.2007.04.003_bib10","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0140-6736(00)04724-3","article-title":"Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial","volume":"357","author":"Tashkin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2007.04.003_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(94)90933-4","article-title":"Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation","volume":"343","author":"Silagy","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2007.04.003_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/thx.2005.049502","article-title":"Why does airway inflammation persist after the smoking stops?","volume":"61","author":"Hogg","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2007.04.003_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09031936.02.00269802","article-title":"A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease","volume":"19","author":"Casaburi","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2007.04.003_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1183\/09031936.02.00238702","article-title":"On behalf of the Dutch\/Belgian Tiotropium Study Group. Improved health outcomes in patients with COPD during 1yrs treatment with tiotropium","volume":"19","author":"Vincken","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2007.04.003_bib15","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1183\/09031936.04.00116004","article-title":"Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD","volume":"23","author":"O\u2019Donnell","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2007.04.003_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pupt.2004.10.003","article-title":"One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium","volume":"18","author":"Anzueto","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pupt.2007.04.003_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1081\/COPD-200026934","article-title":"Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial","volume":"1","author":"Decramer","year":"2004","journal-title":"COPD"},{"key":"10.1016\/j.pupt.2007.04.003_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1378\/chest.110.1.62","article-title":"Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials","volume":"110","author":"Rennard","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2007.04.003_bib19","first-page":"77","article-title":"Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease","volume":"152","author":"Celli","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2007.04.003_bib20","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1164\/ajrccm.152.3.7663792","article-title":"Standardization of Spirometry, 1994 Update","volume":"152","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2007.04.003_bib21","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jama.272.19.1497","article-title":"For the Lung Health Study Research Group. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study","volume":"272","author":"Anthonisen","year":"1994","journal-title":"JAMA"},{"issue":"Suppl","key":"10.1016\/j.pupt.2007.04.003_bib22","first-page":"79","article-title":"The Spanish version of EuroQol: a description and its applications. European Quality of Life scale","volume":"112","author":"Badia","year":"1999","journal-title":"Med Clin (Barc)"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553907000430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553907000430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T08:26:21Z","timestamp":1546849581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553907000430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S1094553907000430"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2007.04.003","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}